IAC regimen

WikiDoc Resources for IAC regimen

Articles

Most recent articles on IAC regimen

Most cited articles on IAC regimen

Review articles on IAC regimen

Articles on IAC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on IAC regimen

Images of IAC regimen

Photos of IAC regimen

Podcasts & MP3s on IAC regimen

Videos on IAC regimen

Evidence Based Medicine

Cochrane Collaboration on IAC regimen

Bandolier on IAC regimen

TRIP on IAC regimen

Clinical Trials

Ongoing Trials on IAC regimen at Clinical Trials.gov

Trial results on IAC regimen

Clinical Trials on IAC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on IAC regimen

NICE Guidance on IAC regimen

NHS PRODIGY Guidance

FDA on IAC regimen

CDC on IAC regimen

Books

Books on IAC regimen

News

IAC regimen in the news

Be alerted to news on IAC regimen

News trends on IAC regimen

Commentary

Blogs on IAC regimen

Definitions

Definitions of IAC regimen

Patient Resources / Community

Patient resources on IAC regimen

Discussion groups on IAC regimen

Patient Handouts on IAC regimen

Directions to Hospitals Treating IAC regimen

Risk calculators and risk factors for IAC regimen

Healthcare Provider Resources

Symptoms of IAC regimen

Causes & Risk Factors for IAC regimen

Diagnostic studies for IAC regimen

Treatment of IAC regimen

Continuing Medical Education (CME)

CME Programs on IAC regimen

International

IAC regimen en Espanol

IAC regimen en Francais

Business

IAC regimen in the Marketplace

Patents on IAC regimen

Experimental / Informatics

List of terms related to IAC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Idarubicin-Ara C-Cladribine regimen; Idarubicin-Cytarabine-Cladribine regimen

## Overview[edit | edit source]

IAC regimen refers to a regimen consisting of idarubicin, cytarabine (Ara-C), and cladribine used to treat acute myelogenous leukemia.[1]

## Regimen[edit | edit source]

IIdrarubicin

ACytarabine (Ara-C)

CCladribin

## Indications[edit | edit source]

* Acute myelogenous leukemia[1]

## References[edit | edit source]

1. ↑ 1.0 1.1 Juliusson G, Höglund M, Karlsson K, Löfgren C, Möllgård L, Paul C; et al. (2003). "Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study". Br J Haematol. 123 (5): 810–8. PMID 14632771.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)